AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Neuropeptide treatment for dry eye and dry mouth syndromes

Summary

This technology is a combination of anti-inflammatory neuropeptides for topical treatment of dry eye and dry mouth syndromes.

Technology Benefits

Oxytocin, secretin, and vasopressin are already available individually as drug treatmentsTreatment targets underlying cause of dry eye and dry mouth syndromesCan be locally delivered to the affected areas (eyes or mouth)Can be formulated as either an aqueous solution or an ointmentCan be used in combination with other pharmaceutical agents

Technology Application

Topical treatment of dry eye and dry mouth Treatment for blepharitisTreatment for Sjogren’s syndromeProphylactic treatment of dry eye or dry mouth caused by drug-related side effects or in premenopausal womenCombination therapy with other active pharmaceutical agents for allergy treatmentResearch tool to study the inflammatory pathways in dry eye and dry mouth

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here